Cargando…
Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis
When making clinical decisions concerning additional treatment for patients who have undergone radical prostatectomy (RP), adverse laboratory/pathological features are considered major factors. We investigated and compared the prognostic efficacy of adverse laboratory/pathological features in predic...
Autores principales: | Park, Jee Soo, Koo, Kyo Chul, Choi, In Young, Lee, Ji Youl, Hong, Jun Hyuk, Kim, Choung-Soo, Lee, Hyun Moo, Hong, Sung Kyu, Byun, Seok-Soo, Rha, Koon Ho, Chung, Byung Ha, Lee, Kwang Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855645/ https://www.ncbi.nlm.nih.gov/pubmed/31702677 http://dx.doi.org/10.1097/MD.0000000000017931 |
Ejemplares similares
-
Re-stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry
por: Lee, Kwang Suk, et al.
Publicado: (2018) -
Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
por: Heo, Ji Eun, et al.
Publicado: (2019) -
Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy
por: Lee, Jung Keun, et al.
Publicado: (2015) -
Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry
por: Hah, Yoon Soo, et al.
Publicado: (2018) -
Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)